36.4 A Phase 3 Registration Trial of Delayed-Release and Extended-Release Methylphenidate (HLD200) in the Treatment of Early Morning Functioning Impairments in Children with Attention-Deficit/Hyperactivity Disorder

2016 ◽  
Vol 55 (10) ◽  
pp. S315
Author(s):  
Steven R. Pliszka
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Extended Release ◽  
Early Morning ◽  
Phase 3 ◽  
Hyperactivity Disorder ◽  
Delayed Release ◽  
Registration Trial

scholarly journals Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Akira Iwanami ◽  
Kazuhiko Saito ◽  
Masakazu Fujiwara ◽  
Daiki Okutsu ◽  
Hironobu Ichikawa
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Extended Release ◽  
Extension Study ◽  
Open Label ◽  
Phase 3 ◽  
Safety And Efficacy ◽  
Hyperactivity Disorder

An amendment to this paper has been published and can be accessed via the original article.

Sign in / Sign up

Export Citation Format

Share Document